Close

Allergy Alarm Raised On Pfizer-BioNTech COVID-19 Vaccine

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Novo Nordisk and AWS Enter Strategic AI Partnership to Accelerate Drug Discovery

Novo Nordisk has announced a strategic partnership with Amazon...

Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals

The Trump administration is preparing to announce a new...

Huawei Expands AI Drug Discovery Ambitions Amid Domestic Chip Push and Policy Support

Huawei intends to deepen its artificial intelligence partnerships with...
- Advertisement -
  • 02 NHS Workers have reportedly suffered from allergic reactions from the first jab of Pfizer-BioNtech COVID-19 vaccine in the UK.
  • MHRA has issued an advisory asking people with an allergic history to refrain from vaccination.

An air of apprehension is doing rounds as this week sees the UK administering the much-awaited Pfizer COVID vaccine shots to its citizens. Two days on and the first warning signal has been issued by British Healthcare regulator asking people with a history of allergies not to take the vaccine. This advisory came to the fore as two NHS healthcare workers suffered allergic reactions to the first jab.

Since this has taken place, an advisory has been floated by MHRA to people who are easily susceptible to medicines, food, and vaccines. These allergic reactions were however not seen across the sample size during the extensive clinical trials that were conducted. The two healthcare workers developed an anaphylactoid reaction shortly after they were administered the COVID-19 vaccine. Although they are stable now, yet a few eyebrows are already raised doubting the prolonged effects of the vaccine. The reactions caused due to anaphylactoid mostly appear as skin rashes, breathlessness and a dip in the blood pressure.

Pfizer has confirmed that they have been advised by the MHRA about the two yellow card reports and are giving the agency all the required support in the investigation.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Novo Nordisk and AWS Enter Strategic AI Partnership to Accelerate Drug Discovery

Novo Nordisk has announced a strategic partnership with Amazon...

Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals

The Trump administration is preparing to announce a new...

Huawei Expands AI Drug Discovery Ambitions Amid Domestic Chip Push and Policy Support

Huawei intends to deepen its artificial intelligence partnerships with...

McKesson to Acquire Precision Medicine Group for $2.25 Billion

US-based healthcare services provider McKesson has agreed to acquire...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »